Benefit from the boom in healthcare Artificial Intelligence (updated)
This Artificial Intelligence data analytics company, with considerable expertise in neuroscience, had been growing fast over recent years and, following recent share price falls, now looks cracking value. Our in-depth commentary here highlights its appeal in a sector which is predicted to grow significantly over the coming years. The order book offers plenty of visibility and this fascinating business is certainly worth a close look. News of encouraging results from a drug being developed for Alzheimers disease is positive. (IHT qualifying)
IXICO (LON:IXI) is an Artificial Intelligence (‘AI’) data analytics company delivering intelligent insights in neuroscience. Its purpose is to advance medicine and human health in neuroscience by converting raw clinical trial data into clinically meaningful information.
Continue reading our content…
- Unlimited access to our market-beating portfolios
- In-depth coverage of many of the world’s great companies
- Unique insights from our top research team
- Company and markets insights
- Sponsored content
- Podcasts
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on IXICO PLC
Benefit from the boom in healthcare Artificial Intelligence (updated)
This Artificial Intelligence data analytics company, with considerable expertise in neuroscience, had been growing fast over…
Where a 7% dividend yield hides a multitude of issues
Updates covered here include a trading update from an unusual provider of alternative finance solutions, which comes…
